Dr. Samadi, leading prostate cancer surgeon, continues to stress the importance and efficacy of prostate cancer PSA screening. Despite government health panel recommendations to the contrary, Dr. Samadi urges men to continue with annual PSA tests and discuss the results with their doctors, in conjunction with risk factor analyses. While not all elevated PSA levels indicate prostate cancer, Dr. Samadi believes the testing is invaluable in diagnosing prostate cancer. Acknowledging concerns over urinary and sexual function risks of surgery, he believes the medical community must concentrate efforts on improving surgical outcomes by bettering surgeon expertise. Dr. Samadi is Vice Chairman of the Department of Urology and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center.